Gratwohl A.; Sureda A.; Cornelissen J.; Apperley J.; Dreger P.; Duarte R.; Greinix H. T.; Mc Grath E.; Kroeger N.; Lanza F.; Nagler A.; Snowden J. A.; Niederwieser D.; Brand R., Alloreactivity: the Janus-face of hematopoietic stem cell transplantation, «LEUKEMIA», 2017, 31, pp. 1752 - 1759 [articolo]Open Access
De Giorgi U.; Nicolas-Virelizier E.; Badoglio M.; Bader P.; Richard S.; Maertens J.; Lanza F.; Bregni M., High-Dose Chemotherapy for Adult-Type Ovarian Granulosa Cell Tumors: A Retrospective Study of the European Society for Blood and Marrow Transplantation, «INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER», 2017, 27, pp. 248 - 251 [articolo]
Passweg J. R.; Baldomero H.; Bader P.; Bonini C.; Cesaro S.; Dreger P.; Duarte R. F.; Dufour C.; Kuball J.; Farge-Bancel D.; Gennery A.; Kroger N.; Lanza F.; Nagler A.; Sureda A.; Mohty M., Impact of drug development on the use of stem cell transplantation: A report by the European Society for Blood and Marrow Transplantation (EBMT), «BONE MARROW TRANSPLANTATION», 2017, 52, pp. 191 - 196 [articolo]
Necchi A.; Lo Vullo S.; Bregni M.; Rosti G.; Mariani L.; Raggi D.; Giannatempo P.; Secondino S.; Schumacher K.; Massard C.; Kanfer E.; Oechsle K.; Laszlo D.; Michieli M.; Ifrah N.; Mercier M.; Crysandt M.; Wuchter P.; Nagler A.; Wahlin A.; Martino M.; Badoglio M.; Pedrazzoli P.; Lanza F., Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012, «CLINICAL GENITOURINARY CANCER», 2017, 15, pp. 163 - 167 [articolo]
De Giorgi U.; Richard S.; Badoglio M.; Kanfer E.; Bourrhis J. H.; Nicolas-Virelizier E.; Vettenranta K.; Lioure B.; Martin S.; Dreger P.; Schuler M. K.; Thomson K.; Scarpi E.; Rosti G.; Selle F.; Mangili G.; Lanza F.; Bregni M., Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: A retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT), «ANNALS OF ONCOLOGY», 2017, 28, pp. 1910 - 1916 [articolo]
Passweg J. R.; Baldomero H.; Bader P.; Bonini C.; Duarte R. F.; Dufour C.; Gennery A.; Kroger N.; Kuball J.; Lanza F.; Montoto S.; Nagler A.; Snowden J. A.; Styczynski J.; Mohty M., Use of haploidentical stem cell transplantation continues to increase: The 2015 European Society for Blood and Marrow Transplant activity survey report, «BONE MARROW TRANSPLANTATION», 2017, 52, pp. 811 - 817 [articolo]
Trojani, Alessandra; Pungolino, Ester; Rossi, Giuseppe; D'Adda, Mariella; Lodola, Milena; Camillo, Barbara Di; Perego, Alessandra; Turrini, Mauro; Orlandi, Ester; Borin, Lorenza; Iurlo, Alessandra; Malato, Simona; Spina, Francesco; Latargia, Maria Luisa; Lanza, Francesco; Artale, Salvatore; Anghilieri, Michela; Carraro, Maria Cristina; Canal, Gabriella De; Morra, Enrica; Cairoli, Roberto, Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment, «DISEASE MARKERS. SECTION A, CANCER BIOMARKERS», 2017, 21, pp. 41 - 53 [articolo]
Lanza F.; Lazzari M. C.; Brambilla P.; Di Martino G.; Spedini P., An unusual association of paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, and diffuse large B-cell non-Hodgkin lymphoma in a Caucasian man, «ANNALS OF HEMATOLOGY», 2016, 95, pp. 1555 - 1557 [articolo]
CAVAZZINI, Francesco; CAMPIONI, Diana; Ferrari, Luisa; Buldini, Barbara; Bardi, Maria Antonella; Michielotto, Barbara; Lazzari, Maria Cristina; Ongari, Manuele; Dabusti, Melissa; Daghia, Giulia; Sofritti, Olga; Basso, Giuseppe; Lanza, Francesco; CUNEO, Antonio, Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia, «CYTOMETRY. PART B, CLINICAL CYTOMETRY», 2016, 90, pp. 247 - 256 [articolo]
Passweg J. R.; Baldomero H.; Bader P.; Bonini C.; Cesaro S.; Dreger P.; Duarte R. F.; Dufour C.; Kuball J.; Farge-Bancel D.; Gennery A.; Kroger N.; Lanza F.; Nagler A.; Sureda A.; Mohty M., Hematopoietic stem cell transplantation in Europe 2014: More than 40 000 transplants annually, «BONE MARROW TRANSPLANTATION», 2016, 51, pp. 786 - 792 [articolo]
Martino M.; Lanza F.; Pavesi L.; Ozturk M.; Blaise D.; Leno Nunez R.; Schouten H. C.; Bosi A.; De Giorgi U.; Generali D.; Rosti G.; Necchi A.; Ravelli A.; Bengala C.; Badoglio M.; Pedrazzoli P.; Bregni M., High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry, «BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION», 2016, 22, pp. 475 - 481 [articolo]
Musso M.; Messina G.; Di Renzo N.; Di Carlo P.; Vitolo U.; Scalone R.; Marcacci G.; Scalzulli P. R.; Moscato T.; Matera R.; Crescimanno A.; Santarone S.; Orciuolo E.; Merenda A.; Pavone V.; Pastore D.; Donnarumma D.; Carella A. M.; Ciochetto C.; Cascavilla N.; Mele A.; Lanza F.; Di Nicola M.; Bonizzoni E.; Pinto A., Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen, «BRITISH JOURNAL OF HAEMATOLOGY», 2016, 172, pp. 111 - 121 [articolo]
Bregni M.; Badoglio M.; Pedrazzoli P.; Lanza F., Is allogeneic transplant for solid tumors still alive?, «BONE MARROW TRANSPLANTATION», 2016, 51, pp. 751 - 752 [articolo]
Saraceni, Francesco; Agostini, Vanessa; Vincenzi, Daniele; Lanza, Francesco, Post-thaw viability of cryopreserved peripheral blood stem cells: what are we actually looking at?, «DRUGS AND CELL THERAPIES IN HEMATOLOGY», 2016, 2016, pp. 85 - 94 [articolo]
Necchi A.; Miceli R.; Bregni M.; Bokemeyer C.; Berger L. A.; Oechsle K.; Schumacher K.; Kanfer E.; Bourhis J. H.; Massard C.; Laszlo D.; Montoro J.; Flechon A.; Arpaci F.; Secondino S.; Wuchter P.; Dreger P.; Crysandt M.; Worel N.; Kruger W.; Ringhoffer M.; Unal A.; Nagler A.; Campos A.; Wahlin A.; Michieli M.; Sucak G.; Donnini I.; Schots R.; Ifrah N.; Badoglio M.; Martino M.; Raggi D.; Giannatempo P.; Rosti G.; Pedrazzoli P.; Lanza F., Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: A study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party, «BONE MARROW TRANSPLANTATION», 2016, 51, pp. 384 - 390 [articolo]